Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The primary approach remains non-pharmacologic
Your first 4-6 weeks of treatment will be closely monitored to ensure safety and effectiveness
Recognizing Signs of Interaction Symptoms to Watch For Patients should stay alert to signs of drug interactions, including persistent nausea, dizziness, fluctuating blood sugar levels, and worsening digestive symptoms
Nutritional Support for Hair Loss and GLP-1 Therapy
Food and Drug Administration (FDA) on the 1st approved 'Foundayo (ingredient name: orforglipron),' an oral obesity treatment developed by Eli Lilly, the company that supplies the obesity drug 'Mounjaro.' This is the second oral GLP-1 class obesity treatment to be approved, following the pill form of Novo Nordisk's 'Wegovy' last December
The Myers Cocktail IV is a potent intravenous infusion of essential vitamins and minerals, including vitamin C, B vitamins, magnesium, and calcium
